Posttherapy [18F] fluorodeoxyglucose positron emission tomography in carcinoma of the cervix: Response and outcome

Journal of Clinical Oncology

Volumn 22, Issue 11, 2004, Pages 2167-2171

  Grigsby, Perry W ^a   Siegel, Barry A ^a   Dehdashti, Farrokh ^a   Rader, Janet ^a   Zoberi, Imran ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; FLUORODEOXYGLUCOSE F 18; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ARTICLE; BRACHYTHERAPY; CANCER SURVIVAL; HAZARD ASSESSMENT; HUMAN; IRRADIATION; LYMPH NODE; MEDICAL RECORD; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGNOSIS; TREATMENT OUTCOME; UTERINE CERVIX CARCINOMA; WHOLE BODY TOMOGRAPHY; COMPUTER ASSISTED EMISSION TOMOGRAPHY; FEMALE; MORTALITY; PREDICTION AND FORECASTING; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; RISK; SCINTISCANNING; SURVIVAL; TUMOR RECURRENCE; UTERINE CERVIX TUMOR;

FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; NEOPLASM RECURRENCE, LOCAL; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; RISK; SURVIVAL ANALYSIS; TOMOGRAPHY, EMISSION-COMPUTED; UTERINE CERVICAL NEOPLASMS;

EID: 2942642492     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2004.09.035     Document Type: Article

References (15)

1. Rose PG, Adler LP, Rodriguez M, et al: Positron emission tomography for evaluating para-aortic nodal metastasis in locally advanced cervical cancer before surgical staging: A surgicopathologic study. J Clin Oncol 17:41-45, 1999
2. Narayan K, Hicks RJ, Jobling T, et al: A comparison of MRI and PET scanning in surgically staged loco-regional advanced cervical cancer: Potential impact on treatment. Int J Gynecol Cancer 11:263-271, 2001
3. Grigsby PW, Siegel BA, Dehdashti F: Lymph node staging by positron emission tomography in patients with carcinoma of the cervix. J Clin Oncol 19:3745-3749, 2001
4. Ryu SY, Kim MH, Choi SC, et al: Detection of early recurrence with 18F-FDG PET in patients with cervical cancer. J Nucl Med 44:347-352, 2003
5. Havrilesky LJ, Wong TZ, Secord AA, et al: The role of PET scanning in the detection of recurrent cervical cancer. Gynecol Oncol 90:186-190, 2003
6. Kostakoglu L, Goldsmith SJ: 18F-FDG PET: evaluation of the response to therapy for lymphoma and for breast, lung, and colorectal carcinoma. J Nucl Med 44:224-239, 2003
7. Grigsby PW, Siegel BA, Dehdashti F, et al: Posttherapy surveillance monitoring of cervical cancer by FDG-PET. Int J Radiat Oncol Biol Phys 55:907-913, 2003
8. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958
9. Breslow N: A generalized Kruskal-Wallis test for comparing K samples subject to unequal patterns of censorship. Biometrika 57:579-594, 1970
10. Cox DR: Regression models and life tables. J R Stat Soc 34:187-220, 1972
11. Machida S, Ohwada M, Saga Y, et al: Abnormal fragile histidine triad expression in advanced cervical cancer and evaluation of its utility as a prognostic factor. Oncology 65:89-93, 2003
12. Jacobs AJ, Paris C, Perez CA, et al: Short-term persistence of carcinoma of the uterine cervix after radiation: An indicator of long-term prognosis. Cancer 57:944-950, 1986
13. Bodurka-Bevers D, Morris M, Eifel P, et al: Posttherapy surveillance of women with cervical cancer: An outcomes analysis. Gynecol Oncol 78:187-193, 2000
14. Ansink A. De Barros-Lopes A, Monaghan JM: Recurrent stage IB cervcial carcinoma: Evaluation of the effectiveness of routine follow-up surviellance. Br J Obstet Gynaecol 103:1156-1158, 1996
15. Keys HM, Bundy BN, Stehman FB, et al: Radiation therapy with and without extrafascial hysterectomy for bulky stage IB cervical carcinoma: A randomized trial of the Gynecologic Oncology Group. Gynecol Oncol 89:343-353, 2003